Cranswick PLC (CWK)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 5,200.00 |
|---|---|
| 52-week range | 4,701.44 – 5,720.49 |
| Return, 1 month / 3 months | +2.8% / −4.2% |
| Return, 1 year / 3 years | +5.3% / +58.1% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 17.8% |
| Worst drawdown (1 year) | -11.6% |
| Average daily value traded | 751.44M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cranswick PLC is a British food producer based in Hull that makes fresh and cooked meat products, including pork, poultry, sausages, bacon and ready-to-eat meals. It supplies supermarkets, food service operators and other food businesses, and it runs its own farming and processing operations to control quality from farm to pack. Its customers are mainly retailers and caterers across the United Kingdom, and the company also exports some products to overseas markets.
Cranswick PLC trades under the code CWK on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cranswick PLC (CWK) trades on the London Exchange in UK. It last closed at GBX 5,200.00 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 810 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.3% and over the last three months it fell 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.8% | ||
| From 52-week high | -7.2% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.2% | ||
| 6-month return | -1.5% | ||
| 12-month return, skipping the last month | 2.5% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.6% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 751.44M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +2.8% |
| 3 months | −4.2% |
| 6 months | −1.5% |
| 1 year | +5.3% |
| 3 years | +58.1% |
| 5 years | +65.5% |
Signals
| 50-day / 200-day average | 5,168.20 / 5,240.69 |
|---|---|
| Golden / death cross (60 days) | Death, 11 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 125.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | GBP 0.8550 |
| 11 Dec 2025 | GBP 0.2700 |
| 17 Jul 2025 | GBP 0.7600 |
| 12 Dec 2024 | GBP 0.2500 |
| 18 Jul 2024 | GBP 0.6730 |
| 14 Dec 2023 | GBP 0.2270 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.